| Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T-cell dysfunction N Singh, YG Lee, O Shestova, P Ravikumar, KE Hayer, SJ Hong, XM Lu, ... Cancer discovery 10 (4), 552-567, 2020 | 224 | 2020 |
| An NK-like CAR T cell transition in CAR T cell dysfunction CR Good, MA Aznar, S Kuramitsu, P Samareh, S Agarwal, G Donahue, ... Cell 184 (25), 6081-6100. e26, 2021 | 220 | 2021 |
| In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine K Muthumani, BD Griffin, S Agarwal, SB Kudchodkar, EL Reuschel, ... npj Vaccines 1 (1), 1-11, 2016 | 141 | 2016 |
| Potentiating adoptive cell therapy using synthetic IL-9 receptors A Kalbasi, M Siurala, LL Su, M Tariveranmoshabad, LK Picton, ... Nature 607 (7918), 360-365, 2022 | 55 | 2022 |
| Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody K Muthumani, L Marnin, SB Kudchodkar, A Perales-Puchalt, H Choi, ... Cancer Immunology, Immunotherapy 66, 1577-1588, 2017 | 39 | 2017 |
| Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells S Agarwal, MA Aznar, AJ Rech, CR Good, S Kuramitsu, T Da, M Gohil, ... Immunity 56 (10), 2388-2407. e9, 2023 | 38 | 2023 |
| Antimicrobial Peptides as Anti-Infectives against Staphylococcus epidermidis S Agarwal, G Sharma, S Dang, S Gupta, R Gabrani Medical Principles and Practice 25 (4), 301-308, 2016 | 35 | 2016 |
| LFA-1 signals to promote actin polymerization and upstream migration in T cells NH Roy, SHJ Kim, A Buffone Jr, D Blumenthal, B Huang, S Agarwal, ... Journal of cell science 133 (17), jcs248328, 2020 | 32 | 2020 |
| Harnessing CAR T-cell insights to develop treatments for hyperinflammatory responses in patients with COVID-19 S Agarwal, CH June Cancer discovery 10 (6), 775-778, 2020 | 32 | 2020 |
| Anti-OspA DNA-encoded monoclonal antibody prevents transmission of spirochetes in tick challenge providing sterilizing immunity in mice Y Wang, R Esquivel, S Flingai, ZA Schiller, A Kern, S Agarwal, J Chu, ... The Journal of infectious diseases 219 (7), 1146-1150, 2019 | 19 | 2019 |
| Production of human Crispr-engineered Car-T cells S Agarwal, N Wellhausen, BL Levine, CH June JoVE (Journal of Visualized Experiments), e62299, 2021 | 17 | 2021 |
| Better living through chemistry: CRISPR/Cas engineered T cells for cancer immunotherapy N Wellhausen, S Agarwal, PC Rommel, SI Gill, CH June Current opinion in immunology 74, 76-84, 2022 | 16 | 2022 |
| Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma K Watanabe, AM Gomez, S Kuramitsu, M Siurala, T Da, S Agarwal, ... Blood advances 7 (14), 3416-3430, 2023 | 14 | 2023 |
| Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge H Choi, SB Kudchodkar, EL Reuschel, K Asija, P Borole, S Agarwal, ... Human Vaccines & Immunotherapeutics 16 (4), 907-918, 2020 | 12 | 2020 |
| Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T-cell dysfunction. Cancer Discov 10: 552–567 N Singh, YG Lee, O Shestova, P Ravikumar, KE Hayer, SJ Hong, XM Lu, ... CD-19-0813. PMID: 32001516. PMCID: PMC7416790, 2020 | 9 | 2020 |
| Epitope editing in hematopoietic cells enables CD45-directed immune therapy N Wellhausen, AK Rennels, S Lesch, S Agarwal, B Charria, G Choi, ... Blood 140 (Supplement 1), 862-864, 2022 | 8 | 2022 |
| In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine. Npj Vaccines. 2016; 1: 16021 K Muthumani, BD Griffin, S Agarwal, SB Kudchodkar, EL Reuschel, ... | 8 | 2016 |
| In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine. NPJ Vaccines 1: 16021 K Muthumani, BD Griffin, S Agarwal, SB Kudchodkar, EL Reuschel, ... | 6 | 2016 |
| Harnessing CAR T-cell insights to develop treatments for hyperinflammatory responses in patients with COVID-19. Cancer Discov. 2020; 10 (6): 775–8 S Agarwal, CH June CD-20-0473.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 6 | |
| Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptors A Kalbasi, M Siurala, LL Su, M Tariveranmoshabad, LK Picton, ... Nature 612 (7938), E10, 2022 | 2 | 2022 |
